Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells:: improvement following anti-tumor necrosis factor-α antibody therapy

被引:207
作者
Papadaki, HA
Kritikos, HD
Valatas, V
Boumpas, DT
Eliopoulos, GD
机构
[1] Univ Crete, Sch Med, Dept Hematol & Rheumatol, Iraklion, Greece
[2] Univ Crete, Sch Med, Dept Clin Immunol & Allergiol, Iraklion, Greece
关键词
D O I
10.1182/blood-2002-01-0136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circumstantial evidence has implicated tumor necrosis factor a (TNF-alpha) in the pathogenesis of anemia of chronic disease (ACD) in rheumatoid arthritis (RA). We investigated the role of TNF-alpha in erythropoiesis of patients with active RA (n = 40) and the effect of anti-TNF-alpha antibody administration (cA2). Patients with RA had lower numbers of CD34(+)/CD71(+) and CD36(-)/glycophorin A(+) (glycoA(+)) bone marrow (BM) cells and increased proportions of apoptotic cells within the CD34(+)/CD71(+) and CD36(+)/glycoA(+) cell compartments, compared to healthy controls (n = 24). Erythroid burst-forming units (BFU-Es) obtained by BM mononuclear or purified CD34(+) cells were significantly lower in RA patients compared to controls. These abnormalities were more pronounced among patients with ACD. Increased TNF-alpha levels in patient long-term BM culture supernatants inversely correlated with BFU-Es and hemoglobin levels and positively with the percentage of apoptotic CD34(+)/CD71(+) and CD36(+)/glycoA(+) cells. Following cA2 therapy, a normalization was documented in the number of CD34(+)/CD71(+) and CD36(-)/glycoA(+) cells, the number of BFU-Es, and the proportion of apoptotic CD34+/CD71+ and CD36+/glycoA+ cells, which was associated with a significant increase in hemoglobin levels compared to baseline. Recovery from anemia was more prominent In patients with ACID. The exogenous addition of an anti-TNF-alpha. antibody In the cultures Increased BFU-E number In patients prior to cA2 treatment but not after treatment, further substantiating the Inhibitory role of TNF-alpha on patients' erythropoiesis. We conclude that TNIF-alpha-mediated apoptotic depletion of BM erythroid cells may account for ACD in RA and that cA2 administration may ameliorate ACD In these patients by down-regulating the apoptotic mechanisms involved in erythropoiesis.
引用
收藏
页码:474 / 482
页数:9
相关论文
共 50 条
  • [1] ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319
  • [2] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [3] INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM
    ATKINS, MB
    KAPPLER, K
    MIER, JW
    ISAACS, RE
    BERKMAN, EM
    [J]. BLOOD, 1995, 86 (04) : 1288 - 1291
  • [4] THE PATHOGENESIS OF ANEMIA IN RHEUMATOID-ARTHRITIS - A CLINICAL AND LABORATORY ANALYSIS
    BAER, AN
    DESSYPRIS, EN
    KRANTZ, SB
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 19 (04) : 209 - 223
  • [5] INADEQUATE ERYTHROPOIETIN RESPONSE TO ANEMIA - DEFINITION AND CLINICAL RELEVANCE
    BAROSI, G
    [J]. ANNALS OF HEMATOLOGY, 1994, 68 (05) : 215 - 223
  • [6] INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM
    BERNAD, A
    KOPF, M
    KULBACKI, R
    WEICH, N
    KOEHLER, G
    GUTIERREZRAMOS, JC
    [J]. IMMUNITY, 1994, 1 (09) : 725 - 731
  • [7] SERUM ERYTHROPOIETIN IN RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES - RELATIONSHIP TO ANEMIA AND THE EFFECT OF ANTIINFLAMMATORY TREATMENT
    BIRGEGARD, G
    HALLGREN, R
    CARO, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (04) : 479 - 483
  • [8] The hematological effects of folate analogs: Implications for using the dihydrofolate reductase gene for in vivo selection
    Blau, CA
    Neff, T
    Papayannopoulou, T
    [J]. HUMAN GENE THERAPY, 1996, 7 (17) : 2069 - 2078
  • [9] Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis
    Cazzola, M
    Ponchio, L
    deBenedetti, F
    Ravelli, A
    Rosti, V
    Beguin, Y
    Invernizzi, R
    Barosi, G
    Martini, A
    [J]. BLOOD, 1996, 87 (11) : 4824 - 4830
  • [10] CHARBORD P, 1995, HEMATOPOIETIC STEM C, P151